These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2078119)

  • 1. [General modality for evaluation of drugs in pediatry].
    Autret E
    Arch Fr Pediatr; 1990 Nov; 47(9):627-8. PubMed ID: 2078119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of new drugs].
    Lewis PJ
    Rev Prat; 1982 Sep; 32(41-42):2649-50 passim. PubMed ID: 7146802
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of drugs].
    Wasielewski S
    Med Monatsschr Pharm; 1992 Feb; 15(2):34. PubMed ID: 1579074
    [No Abstract]   [Full Text] [Related]  

  • 4. [Methods for clinical study of antineoplastic drugs].
    Lichinitser MR
    Vopr Onkol; 1986; 32(8):93-8. PubMed ID: 3765515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodology of clinical trials on new drugs in epilepsy.
    Morselli PL
    Funct Neurol; 1986; 1(4):503-11. PubMed ID: 3609878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical drug trials. 1: The 4 phases of clinical trials].
    Gleiter CH; Bieck PR
    Fortschr Med; 1991 Feb; 109(5):136-7. PubMed ID: 2045036
    [No Abstract]   [Full Text] [Related]  

  • 7. How experimental drugs are tested in humans.
    Flieger K
    Pediatr Infect Dis J; 1989 Mar; 8(3):160-2. PubMed ID: 2710587
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protocol for the clinical pharmacology study of the hypnotic properties of a drug].
    Allain H; Milon D; van den Driessche J
    Therapie; 1984; 39(1):13-6. PubMed ID: 6463940
    [No Abstract]   [Full Text] [Related]  

  • 9. [Continuing education. Clinical trials].
    Sökeland J
    Urologe A; 1990 Nov; 29(6):W41-2. PubMed ID: 2291253
    [No Abstract]   [Full Text] [Related]  

  • 10. [A few reflexion themes on the method in therapeutic evaluation].
    Bouvenot G
    Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):703-5. PubMed ID: 1306589
    [No Abstract]   [Full Text] [Related]  

  • 11. [Good clinical practice. Requirements for clinical documentation on the introduction of new drugs].
    Dirach J
    Ugeskr Laeger; 1990 Apr; 152(14):992-4. PubMed ID: 2183456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Foundations of pharmacotherapy. Clinical pharmacology in key words. Drug testing II].
    MMW Munch Med Wochenschr; 1979 Nov; 121(46):46-8. PubMed ID: 117346
    [No Abstract]   [Full Text] [Related]  

  • 13. MRI for development of disease-modifying osteoarthritis drugs.
    Burstein D
    NMR Biomed; 2006 Oct; 19(6):669-80. PubMed ID: 16986116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardized assessment of drug-adverse reaction associations--rationale and experience.
    Venulet J; Ciucci A; Berneker GC
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):381-8. PubMed ID: 7450930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico prediction of clinical efficacy.
    Michelson S; Sehgal A; Friedrich C
    Curr Opin Biotechnol; 2006 Dec; 17(6):666-70. PubMed ID: 17046236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comments on 'Sample size for equivalence trials: A case study from a vaccine lot consistency trial' by J. Ganju, A. Izu and A. Anemona, Statistics in Medicine 2008; 27:3743-3754.
    Kohberger RC
    Stat Med; 2009 Jan; 28(1):177-8, author reply 178-9. PubMed ID: 18937271
    [No Abstract]   [Full Text] [Related]  

  • 17. A 'BOLD' experiment in defining the utility of fMRI in drug development.
    Borsook D; Bleakman D; Hargreaves R; Upadhyay J; Schmidt KF; Becerra L
    Neuroimage; 2008 Aug; 42(2):461-6. PubMed ID: 18598770
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA signals it's open to drug trials that shift midcourse.
    Mathews AW
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817
    [No Abstract]   [Full Text] [Related]  

  • 19. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism, antagonism, or additivity of dietary supplements: application of theory to case studies.
    Borgert CJ; Borgert SA; Findley KC
    Thromb Res; 2005; 117(1-2):123-32; discussion 145-51. PubMed ID: 16023178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.